Sizable seed focus Meridian Street Capital is an early-stage venture investor focused on seed and Series A opportunities at the technology-healthcare intersection, indicating potential interest in founders addressing clinical trials, digital health, patient experience, and cost optimization solutions.

Health-tech partnerships Recent investments include Quilt Health, Myisaachealth, and Jona, signaling a track record and openness to funding startups in clinical trial optimization, digital brain health, and microbiome-related health tech, suggesting alignment with health IT, data analytics, and bioscience ventures.

Strategic value add As a boutique VC with a small team, Meridian Street Capital can offer focused strategic support, introductions to healthcare systems and operators, and potential co-investment leverage with notable firms, appealing to ambitious early-stage startups seeking hands-on guidance.

Financial health signals Reported revenue range of ten to twenty-five million and active seed investments imply available capital for follow-on rounds and potential syndication opportunities with other investors in the health-tech ecosystem.

Geographic and network leverage Based in New York with a nationwide portfolio including Boston-based Quilt Health and other early-stage health-tech companies, Meridian Street Capital can facilitate cross-market introductions and multi-regional growth strategies for portfolio founders.